An undisclosed company has filed a Paragraph IV certification
pertaining to Novartis’ Ritalin LA (methylphenidate
extended-release capsules).
Original post by Google Inc.
Online pharmaceutical prescription news and reviews
An undisclosed company has filed a Paragraph IV certification
pertaining to Novartis’ Ritalin LA (methylphenidate
extended-release capsules).
Original post by Google Inc.
0 Responses to “Novartis' Ritalin LA Faces Patent Challenge”